GLOBAL HEALTH | GLOBAL PARTNERSHIPS | GLOBAL IMPACT

ESC 2018 Presentations by PHRI Investigators

Referring to the European Society of Cardiology (ESC) Congress in Munich, Germany August 25-29, 2018, Population Health Research Institute was “one of the four or five institutions that had the biggest impact at what is the biggest meeting in the world in cardiovascular disease,” Dr. Salim Yusuf said at PHRI Research Day on Sept. 6, 2018.

Presentations by PHRI investigators at ESC 2018 included the following:

Late Breaking Pharmacological Science – Dr. PJ Devereaux

Dr. Devereaux presented on the MANAGE Trial – Dabigatran versus placebo in patients with myocardial injury after noncardiac surgery. 

Clinical Trial Updates- Dr. John Eikelboom

Dr. Eikelboom discussed the COMPASS trial – bleeding and cancer risk in patients with vascular disease treated with Rivaroxaban. At a session called “Satellite Symposium: Setting the COMPASS into new directions,”  he spoke about improved outcomes for patients with chronic Coronary Artery Disease and Peripheral Artery Disease, along with his PHRI peer, Dr. Sonia Anand.

Hot Line Session – Dr. Andrew Mente

Dr. Mente spoke about the PURE study results showing the association of dietary quality and risk of cardiovascular disease and mortality in more than 218,000 people from over 50 countries. He also spoke at a session called How to Eat Right: Should PURE results influence dietary guidelines? where he unveiled new, ongoing work at PHRI about going healthy, globally: a comparison of dietary patterns.

Dr. Mahshid Dehghan, PHRI researcher in nutrition epidemiology, participated in an ESC 2018 session on Nutrition, Malnutrition and Heart Disease, contributing her presentation on “Fats, Carbs, Alcohol: Debunking the Myths of Healthy Nutrition.”

Late Breaking Science in Heart Failure – Dr. Harriette Van Spall

Dr. Harriette Van Spall, a principal investigator in heart failure at PHRI, presents findings from Patient-Centered Care Transitions in Heart Failure (PACT-HF) pragmatic stepped wedge cluster randomized trial during ESC 2018. She also participated in the rapid-fire abstract-based programme, with “Biomarkers reloaded: diagnosis and prognosis of acute heart failure,” on the topic of Predicting risk at the point of care: N-terminal prohormone Brain Natriuretic Peptide (NTproBNP) levels improves performance of the LACE index among patients hospitalized for heart failure.

Dr. Yusuf participated in several sessions, including “Lifestyle choices and blood pressure” – speaking on salt, BP and risk; Satellite symposium on saving lives beyond adherence (his talk, “Are we there yet? Challenges and opportunities in cardiovascular prevention.”)

Dr. Stuart Connolly received the ESC Geoffrey Rose Lecture on Population Sciences, for his talk of prevention of stroke in atrial fibrillation.

VISION Study: Frequency, Causes and Timing of 30-Day Mortality after Noncardiac Surgery

Dr. Jessica Spence, PHR researcher, anesthesiology resident at Hamilton Health Sciences and PhD candidate at McMaster University, working with Dr. PJ Devereaux, participated in Late Breaking Registry Results, on the VISION study, looking at the frequency, causes, and timing of 30-day mortality after noncardiac surgery: analysis of the vascular events in noncardiac surgery patients.

Dr. Jessica Spence presenting at ESC 2018.

Dr. Jessica Spence presenting at ESC 2018.